158 related articles for article (PubMed ID: 14727906)
21. Improving the compaction properties of roller compacted calcium carbonate.
Bacher C; Olsen PM; Bertelsen P; Kristensen J; Sonnergaard JM
Int J Pharm; 2007 Sep; 342(1-2):115-23. PubMed ID: 17582712
[TBL] [Abstract][Full Text] [Related]
22. A novel fast disintegrating tablet fabricated by three-dimensional printing.
Yu DG; Branford-White C; Yang YC; Zhu LM; Welbeck EW; Yang XL
Drug Dev Ind Pharm; 2009 Dec; 35(12):1530-6. PubMed ID: 19929213
[TBL] [Abstract][Full Text] [Related]
23. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous investigation of the liquid transport and swelling performance during tablet disintegration.
Al-Sharabi M; Markl D; Mudley T; Bawuah P; Karttunen AP; Ridgway C; Gane P; Ketolainen J; Peiponen KE; Rades T; Zeitler JA
Int J Pharm; 2020 Jun; 584():119380. PubMed ID: 32407939
[TBL] [Abstract][Full Text] [Related]
26. Fast-melting tablets based on highly plastic granules.
Fu Y; Jeong SH; Park K
J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
[TBL] [Abstract][Full Text] [Related]
27. In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets.
Wagner-Hattler L; Wyss K; Schoelkopf J; Huwyler J; Puchkov M
Int J Pharm; 2017 Dec; 534(1-2):50-59. PubMed ID: 28987455
[TBL] [Abstract][Full Text] [Related]
28. Varying efficacy of superdisintegrants in orally disintegrating tablets among different manufacturers.
Mittapalli RK; Qhattal HS; Lockman PR; Yamsani MR
Pharmazie; 2010 Nov; 65(11):805-10. PubMed ID: 21155386
[TBL] [Abstract][Full Text] [Related]
29. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
30. An investigation of the disintegration of tablets in biorelevant media.
Anwar S; Fell JT; Dickinson PA
Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
[TBL] [Abstract][Full Text] [Related]
31. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
[TBL] [Abstract][Full Text] [Related]
32. Compressibility and compactibility of granules produced by wet and dry granulation.
Bacher C; Olsen PM; Bertelsen P; Sonnergaard JM
Int J Pharm; 2008 Jun; 358(1-2):69-74. PubMed ID: 18407441
[TBL] [Abstract][Full Text] [Related]
33. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
[TBL] [Abstract][Full Text] [Related]
34. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
Asker AF; Saied KM; Abdel-Khalek MM
Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
[TBL] [Abstract][Full Text] [Related]
35. Cyclodextrin polymer, a new tablet disintegrating agent.
Fenyvest E; Antal B; Zsadon B; Szejtli J
Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of orally disintegrating tablets containing the mosapride resin complex.
Wu T; Wang G; Shi C; Li J; Zhao N; Dong Z; Pan W; Zhang X
Acta Pharm; 2018 Jun; 68(2):159-170. PubMed ID: 29702482
[TBL] [Abstract][Full Text] [Related]
37. Formulation and Evaluation of Fast-Disintegrating Sublingual Tablets of Atropine Sulfate: the Effect of Tablet Dimensions and Drug Load on Tablet Characteristics.
Aodah A; Bafail RS; Rawas-Qalaji M
AAPS PharmSciTech; 2017 Jul; 18(5):1624-1633. PubMed ID: 27650282
[TBL] [Abstract][Full Text] [Related]
38. Stability investigation of FCC-based tablets for oral suspension with caffeine and oxantel pamoate as model drugs.
Wagner-Hattler L; Schoelkopf J; Huwyler J; Puchkov M
Drug Dev Ind Pharm; 2019 Feb; 45(2):222-230. PubMed ID: 30260721
[TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
Aly SA; Udeala OK
Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
[TBL] [Abstract][Full Text] [Related]
40. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
Desai PM; Liew CV; Heng PW
Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
